Pacira Biosciences, INC 8-K filings

NASDAQ

29 Feb 2024

PCRX

8-K: Pacira BioSciences Reports Record 2023 Revenues and CFO Transition

Pacira BioSciences announced record full-year revenues of $675 million for 2023, alongside the departure of its CFO, Charles A. Reinhart, III, effective September 30, 2024.